ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $88,641 | -11.3% | 26,460 | +27.4% | 0.00% | -40.0% |
| Q4 2022 | $99,880 | -28.7% | 20,765 | -15.5% | 0.01% | +25.0% |
| Q3 2022 | $140,000 | -27.1% | 24,569 | -6.6% | 0.00% | -33.3% |
| Q2 2022 | $192,000 | +7.3% | 26,304 | +4.2% | 0.01% | +50.0% |
| Q1 2022 | $179,000 | -21.1% | 25,245 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $227,000 | -76.6% | 25,116 | -16.9% | 0.00% | -77.8% |
| Q3 2021 | $971,000 | +62.9% | 30,225 | +23.9% | 0.02% | +80.0% |
| Q2 2021 | $596,000 | -58.1% | 24,403 | -3.6% | 0.01% | -60.0% |
| Q1 2021 | $1,423,000 | -11.5% | 25,312 | -34.3% | 0.02% | -28.6% |
| Q4 2020 | $1,608,000 | – | 38,543 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |